Skip to main content

and
  1. Article

    HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia

    Allogeneic hematopoietic stem cell transplantation (HSCT) is still needed for many children with very high-risk acute leukemia. An HLA-haploidentical family donor is a suitable option for those without an HLA-...

    M. S. Massei, I. Capolsini, E. Mastrodicasa, K. Perruccio in Bone Marrow Transplantation (2023)

  2. No Access

    Article

    Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis

    To address the prognostic value of minimal residual disease (MRD) before unrelated cord blood transplantation (UCBT) in children with acute lymphoblastic leukemia (ALL), we analyzed 170 ALL children transplant...

    A Ruggeri, G Michel, J-H Dalle, M Caniglia, F Locatelli, A Campos in Leukemia (2012)

  3. No Access

    Article

    Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation

    From July 1995 to December 2001, 42 patients with leukemia aged 1–42 years underwent cord blood transplant (CBT) from unrelated, ⩽2 antigen HLA mismatched donors. In all, 26 patients were in ⩽2nd complete remi...

    A P Iori, R Cerretti, L De Felice, M Screnci, A Mengarelli in Bone Marrow Transplantation (2004)

  4. No Access

    Article

    Reciprocal bone marrow transplantation between brother and sister

    A child with AML underwent allogeneic BMT from an HLA-identical sister donor. Prompt and stable trilineage engraftment occurred and after few months he returned to a normal life. Eight years later a primary NH...

    I Rana, RM Pinto, M Caniglia, A Lombardi, G De Rossi in Bone Marrow Transplantation (2002)

  5. No Access

    Article

    Intravenous immune globulin in lysinuric protein intolerance

    In addition to systemic manifestations with skeletal, pulmonary, renal, and haematological signs, lysinuric protein intolerance (LPI), a membrane transport defect of cationic amino acids, is often complicated ...

    C. Dionisi-Vici, L. De Felice, M. El Hachem in Journal of Inherited Metabolic Disease (1998)